Ulcerative Colitis in RemissionNCT01301976
Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis
An observational study of Ulcerative Colitis in Remission, run by UPECLIN HC FM Botucatu Unesp at 1 site in Brazil.
Trial summary
The purpose of this study is to determine the reason patients are deficient in nutrients intake such as antioxidants vitamins. Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Ulcerative Colitis in Remission
- How many people
- 59 participants
- Where
- 1 siteBrazil
- Study dates
- Mar 2009to Feb 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with Ulcerative Colitis in remission
Who may be able to join
- Patients with Ulcerative Colitis in remission
- Age > 18 yo
Who cannot join
- Patients with Ulcerative Colitis in activity
- Those patients with food intake trouble
- Those patients with bowel resected
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Botucatu, São Paulo, 18618-970
About this study
Official title: Nutritional State in Ulcerative Colitis Patients
The purpose of this study is to determine the reason patients are deficient in nutrients intake such as antioxidants vitamins.
- Conditions
- Ulcerative Colitis in Remission
- Keywords
- nutritional state, nutrients intake, ulcerative colitis
- Medical subject headings
- Colitis, Ulcerative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Feb 2011 (estimated)
- Study startMar 2009
- Primary completionMar 2010
- Study completionFeb 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ulcerative Colitis in RemissionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Cross-sectional
- Enrolment
- 59 participants (actual)
Sponsor and investigators
- Lead sponsor
- UPECLIN HC FM Botucatu Unesp
- Sponsor type
- University, hospital or other
- Collaborators
- Fundação de Amparo à Pesquisa do Estado de São Paulo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01301976
- Sponsor's protocol ID
- upeclin/HC/FMB-Unesp-49
- Status last verified
- Feb 2011
- First submitted
- 21 Feb 2011
- Last updated
- 23 Feb 2011
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 23 Feb 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nutritional State in Ulcerative Colitis Patients
- ClinicalTrials.gov ID
- NCT01301976
- Acronym / sponsor ID
- upeclin/HC/FMB-Unesp-49
- Conditions
- Ulcerative Colitis in Remission
- Keywords
- nutritional state, nutrients intake, ulcerative colitis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 59 participants (actual)
- Lead sponsor
- UPECLIN HC FM Botucatu UnespUniversity, hospital or other
- Collaborators
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Study start
- Mar 2009
- Primary completion
- Mar 2010 (actual)
- Study completion
- Feb 2011 (actual)
- First posted
- 23 Feb 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the reason patients are deficient in nutrients intake such as antioxidants vitamins.
Study design
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with Ulcerative Colitis in remission
Key inclusion criteria (2 listed)
- Patients with Ulcerative Colitis in remission
- Age > 18 yo
Key exclusion criteria (3 listed)
- Patients with Ulcerative Colitis in activity
- Those patients with food intake trouble
- Those patients with bowel resected
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Feb 2011.
Related trials for Ulcerative Colitis in Remission
Active, not recruitingObservational study
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Colitis, Ulcerative
Active, not recruitingPhase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Recruiting
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
IBS, Ulcerative Colitis, Active
Recruiting
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Ulcerative Colitis (UC)
RecruitingPhase 4
The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited From Outpatient Clinic of Inflammatory Bowel Disease (IBD) of the National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, Egypt
Ulcerative Colitis (UC)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Ulcerative Colitis in Remission, run by UPECLIN HC FM Botucatu Unesp at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2011.